Liverpool leads global innovation with new Health Enterprise Hub

Health and Life Sciences leaders across the Liverpool City Region have joined forces to create the most connected health and life sciences system in the UK.

The Health Enterprise Hub – a collaborative between Liverpool City Region Local Enterprise Partnership, Cheshire and Merseyside Strategic Clinical Networks, Liverpool Health Partners and the North West Coast Academic Health Science Network – presents Liverpool City Region as the first-choice location for investors and innovators in health and life sciences.

The Hub will act as a focal point for academic and clinical researchers, businesses, technology experts, doctors and consultants to collaborate and create a new generation of medicines, diagnostics and services that can be developed and implemented across the world.

Alan Welby, executive director of Liverpool City Region Local Enterprise Partnership said:

“Our world-class partners and networks have invested in the Health Enterprise Hub to provide innovators and business investors with a one-stop-shop to take new products, ideas and health solutions to market quickly.

“We understand how difficult it can be to navigate this complex system and reach the right people. The Hub, unique in the UK, will make it easy for innovators to move fast and deliver solutions that transform patient care worldwide. There really isn’t a better time to invest in all that the Liverpool region has to offer.”

Four key pathways “Discover, Accelerate, Transform, Invest” provide a direct route to the relevant organisations and people.

The ‘Discover’ pathway provides clinical and academic researchers with support, training, access to funding and facilities to explore new research into areas such as genomics, proteomics, imaging and bioinformatics.

The ‘Accelerate’ pathway provides businesses and innovators with new ways to convert ideas and prototypes into mass-market products and services that will change how patients use health services in the future.

The ‘Transform’ pathway provides expertise and support to redesign services and treatments to fight many of the world’s most serious diseases such as cancer, heart disease and dementia.

The ‘Invest’ pathway offers practical advice and support for companies to join businesses like Novartis, Unilever and Eli Lilly who are leading the way in fields such as medical research, bio-technology, informatics and medical treatment. This includes accessing the right skills, jobs and funding and finding the right location.

Professor Sir Ian Gilmore Chairman of Liverpool Health Partners said: “This partnership provides a unique opportunity for investors to bring all the main players to the table – from cutting-edge science to healthcare specialists. We are very excited about the opportunities it will create for widespread collaboration, helping solve health problems on a local and global scale.”

Jan Vaughan, associate director at Cheshire and Merseyside Strategic Clinical Networks commented:

“Cheshire & Merseyside Strategic Clinical Networks bring together health and social care commissioners and providers, third sector, patients, carers and communities to make informed and balanced health and care decisions. Our approach, combined with the collaborative power of the Health Enterprise Hub, will transform patient outcomes for the long term and invest in the health of future generations.”

Dr Liz Mear, chief executive of North West Coast Academic Health Science Network added:

“We are delighted to be involved with this very important partnership, through which we will drive innovation in health and life sciences to generate wealth and improve health across the region and beyond.”

More information about the Health Enterprise Hub can be found at

You might also like More from author

Leave A Reply

Your email address will not be published.

Username field is empty.